跳至主要内容
临床试验/CTRI/2022/01/039723
CTRI/2022/01/039723招募中3 期

A prospective study on drug repurposing of olanzapine for prevention and breakthrough treatment of radiotherapy induced nausea and vomiting

Indian Council of Medical Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients aged 18 years or older
  • Radiotherapy naive patients
  • Patients receiving abdominal or pelvic radiotherapy
  • Patients or their care givers willing to provide informed signed consent

排除标准

  • Patients who received less than 15 fractions of radiation therapy
  • Patients with history of brain metastasis & seizure disorder
  • Patients receiving antipsychotic drugs within a window period of 30 days prior radiation therapy
  • Elderly patients with dementia-related psychosis .
  • Patients with uncontrolled diabetes mellitus
  • Patients with drug abuse
  • Allergic to any of the study medications
  • Patients already on systemic corticosteroids
  • Vomiting within the last 24hrs, prior to radiotherapy
  • Previous history of nausea.

研究者

相似试验